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Glioblastoma multiforme (GBM) is a uniformly fatal
brain tumor. The GBM microenvironment includes
abundant tumor-associated macrophages (TAMs) that
predominantly assume a pro-tumor “M2” phenotype
rather than a pro-inflammatory “M1” phenotype. TAMs
suppress T cell activation, produce VEGF, secrete prolif-
erative factors, and encourage tumor invasion and
metastasis. The inhibitory p50 subunit of the NF-kB
transcription factor exhibits markedly increased nuclear
expression in TAMs and M2-polarized macrophages [1],
and p50 knockdown or deletion suppresses expression
of M2-associated factors [1-3]. We hypothesize that
absence of TAM p50 will convert TAMs to a pro-
inflammatory M1 phenotype that will reduce tumor
growth and prolong survival.
The murine glioma cell line GL261-Luc was intracra-
nially implanted into wild-type and p50(-/-) mice.
Tumors grew 6-fold slower in p50(-/-) compared with
wild-type mice, and p50(-/-) mice exhibited significantly
increased survival. RT-qPCR analysis of CD11b+ myeloid
cells isolated from the brains of tumor-bearing mice
revealed decreased M2 marker expression and increased
M1 marker expression in the absence of NF-kB p50. Eva-
luation of tumor-infiltrating T cells indicated that p50
(-/-) mice possess decreased Treg cells, and that more
p50(-/-) CD4 T cells induce IFNg expression after PMA/
Ionomycin stimulation than wild-type CD4 T cells.
When M2-polarized p50(-/-) bone marrow-derived
macrophages (BMM) are co-cultured in vitro with wild-
type T cells, they do not suppress T cell proliferation to
the same extent as wild-type BMM. These data suggest
that NF-kB p50 is an important modulator of the sup-
pressive TAM phenotype in GBM and that deletion of
the gene encoding p50 promotes conversion to a pro-
inflammatory phenotype that is less tumor-permissive.
We anticipate that targeting p50 in combination with
immune checkpoint inhibition might prove synergistic in
facilitating anti-tumor immunity and tumor regression.
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